Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.

Gregory Piazza Alex C Spyropoulos Judith HsiaMark GoldinWilliam J TownerAlan S GoTodd M BullStephen WengConcetta LipardiElliot S Barnathan Marc P Bonacanull null

Published in: Circulation (2023)

gov; Unique identifier: NCT04508023.

Keyphrases